Attached files

file filename
EX-99.3 - LEASE AGREEMENT OF OFFICE BUILDING LOCATED AT ZONE B, 2/F, BUILDING NO.7, BLOCK C, WUXI (HUISHAN) LIFE SCIENCE & TECHNOLOGY INDUSTRIAL PARK, 1699 HUISHAN AVENUE, WUXI, THE P.R.C. - Cellular Biomedicine Group, Inc.cbmg_ex993.htm
EX-99.2 - LEASE AGREEMENT OF OFFICE BUILDING LOCATED AT ROOM E2301 AND 1125, ZONE A, 2/F, WUXI (HUISHAN) LIFE SCIENCE & TECHNOLOGY INDUSTRIAL PARK, 1619 HUISHAN AVENUE, WUXI, THE P.R.C. - Cellular Biomedicine Group, Inc.cbmg_ex992.htm
EX-99.1 - AGREEMENT ON TERMINATION OF COOPERATION WITH JILIN LUHONG REAL ESTATE DEVELOPMENT CO., LTD. - Cellular Biomedicine Group, Inc.cbmg_ex991.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF THE SARBANES-OXLY ACT OF 2002 - Cellular Biomedicine Group, Inc.cbmg_ex311.htm
10-Q - PRIMARY DOCUMENT - Cellular Biomedicine Group, Inc.cbmg_10q.htm
 
Exhibit 32.1
 
CERTIFICATION
 
In connection with the periodic report of Cellular Biomedicine Group, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2016 as filed with the Securities and Exchange Commission (the “Report”), I, Bizuo (Tony) Liu, Chief Executive Officer and Chief Financial Officer (Principal Executive Officer and Principal Financial and Accounting Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of our knowledge:
 
(1)           The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
 
(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
 
 
 
 
 
 
Date: August 8, 2016
By:
/s/ Bizuo (Tony) Liu
 
 
 
Bizuo (Tony) Liu
 
 
 
Chief Executive Officer, Chief Financial Officer and Secretary
 
 
 
 (Principal Executive Officer and Principal Financial and Accounting Officer)